Investor clashes with Akorn board after botched Fresenius tie-up
An investor has urged an Illinois federal court to disregard Akorn’s motion to dismiss their lawsuit, after a merger between the drugmaker and healthcare company Fresenius collapsed following revelations that the drugmaker misrepresented the state of its data.
To read more
Subscribe to Global Data Review
Subscribe and start reading now
The one-stop information source and community touchpoint, with coverage from across the areas of
- Data protection